Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
शेयरों में रैंक #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
शेयर मूल्य
$1.00
अंतिम समन्वयन: 2023-06-01
मार्केट कैप
$30.11M
बदलाव (1 दिन)
2.04%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Angion Biomedica Corp. (ANGN)

श्रेणी

Angion Biomedica Corp. (ANGN) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $1.00 (2023-06-01 को)

दिन का सबसे निम्न समापन मूल्य: $20.49 (2021-02-01 को)
Angion Biomedica Corp. के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2023 18.73%
2022 -70.78%
2021 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.65 -14.34%
AU
$753.28 5.84%
CH